Minimal quality criteria for acceptability of in vivo bio-assays with Bt-proteins

As part of the regulatory authorization process, the potential risks that the cultivation of genetically engineered (GE) plants may pose to non-target organisms (NTOs) and the ecosystem services they provide are assessed in many jurisdictions. A typical risk hypothesis addressed during the environmental risk assessment (ERA) of